{
    "code": "12002707",
    "url": "https:\/\/www.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=12002707",
    "time": "2018-07-20 04:35:27",
    "許可證字號": "內衛藥製字第002707號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "有效日期": "107\/05\/25",
    "發證日期": "59\/04\/10",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHY01200270706",
    "中文品名": "&quot;應元&quot;硫酸甲基新斯狄格明注射液0.025%",
    "英文品名": "INJECTIO NEOSTIGMINAE METHYLSULFATIS 0.025% &quot;Y.Y.&quot;",
    "適應症": "肌無力症、肌萎縮、手術後及產床時之腸管或膀胱之麻痺、末稍血管障礙",
    "劑型": "270注射劑",
    "包裝": "安瓿",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "主成分略述": [
        "NEOSTIGMINEMETHYLSULFATE"
    ],
    "限制項目": "01國　產",
    "申請商名稱": "1704519200  應元化學製藥股份有限公司",
    "主製造廠": {
        "主製造廠": "",
        "製造廠名稱": "1704519300  應元化學製藥股份有限公司",
        "製造廠廠址": "台南市南區新忠路２６號",
        "製造廠公司地址": ""
    },
    "CCC號列": "30049099904 其他醫藥製劑〈不包括第３００２、３００５或３００６節所列者〉包含經混合或未混合產品供治療或預防疾病用，具有劑量（包括經皮給藥形態者）或零售包裝式樣者Other medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1204000920",
            "成分名稱": "NEOSTIGMINE METHYLSULFATE",
            "含量描述": "0.25",
            "含量": "0.2500000000",
            "單位": "MG"
        }
    ]
}